Synthetic Cannabinoid Metabolites Screen, Expanded, Urine
Use
The Synthetic Cannabinoid Metabolites Screen, Expanded, Urine test is designed to detect the presence of synthetic cannabinoid metabolites in urine samples. Synthetic cannabinoids, often known as 'spice,' 'K2,' or designer drugs, have been associated with severe health effects. This test is useful in clinical settings to evaluate potential intoxication or toxicity, support clinical diagnosis, and facilitate appropriate patient management. It helps in understanding patient drug use and aids healthcare providers in designing suitable interventions or treatment plans for the individuals.
Special Instructions
Not provided.
Limitations
There are known interferences with this test, such as FUBINACA 3,3-dimethylbutanoic acid being potentially affected by the presence of quetiapine. Moreover, like all urine-based tests, this screen is limited by the detection window specific to each synthetic cannabinoid's pharmacokinetics and the individual's metabolic differences. False negatives can occur if the metabolites have been fully excreted or if the sensitivity threshold of the assay does not meet the levels present in the urine.
New York Approved
Methodology
Mass Spectrometry (LC-MS/MS)
Biomarkers
Result Turnaround Time
10-16 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
5 mL
Minimum Volume
2.4 mL
Container
Plastic preservative-free urine container
Collection Instructions
Collect 5 mL random urine specimen without preservative. Send specimen refrigerated in a plastic preservative-free urine container.
Storage Instructions
Refrigerate specimen for up to 30 days or freeze for up to 180 days if needed.
Causes for Rejection
Warm thawing OK; Cold thawing OK.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 30 days |
| Refrigerated | 30 days |
| Frozen | 180 days |